PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-1 (1)
 
Clipboard (0)
None

Select a Filter Below
Journals
EJNMMI Research (1)
Authors
Booij, Jan (1)
Boot, Erik (1)
Braak, Breg (1)
Fliers, Eric (1)
Janssen, Ignace M (1)
Serlie, Mireille J (1)
de Weijer, Barbara A (1)
van Amelsvoort, Thérèse A (1)
van de Giessen, Elsmarieke (1)
van de Laar, Arnold (1)
Year of Publication
2011 (1)
Document Types
research-article (1)
1.  Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects 
de Weijer, Barbara A | van de Giessen, Elsmarieke | van Amelsvoort, Thérèse A | Boot, Erik | Braak, Breg | Janssen, Ignace M | van de Laar, Arnold | Fliers, Eric | Serlie, Mireille J | Booij, Jan
EJNMMI Research  2011;1:37.
Background
Obesity is a result of a relative excess in energy intake over energy expenditure. These processes are controlled by genetic, environmental, psychological and biological factors. One of the factors involved in the regulation of food intake and satiety is dopaminergic signalling. A small number of studies have reported that striatal dopamine D2/D3 receptor [D2/3R] availability is lower in morbidly obese subjects.
Methods
To confirm the role of D2/3R in obesity, we measured striatal D2/3R availability, using [123I]IBZM SPECT, in 15 obese women and 15 non-obese controls.
Results
Striatal D2/3R availability was 23% (p = 0.028) lower in obese compared with non-obese women.
Conclusion
This study is an independent replication of the finding that severely obese subjects have lower striatal D2/3R availability. Our findings invigorate the evidence for lower striatal D2/3R availability in obesity and confirm the role of the striatal dopaminergic reward system in obesity.
doi:10.1186/2191-219X-1-37
PMCID: PMC3265412  PMID: 22214469
obesity; dopamine receptor availability; [123I]IBZM SPECT
Related Articles
Results 1-1 (1)